ArticleCancers2022

CD163 as a Potential Biomarker in Colorectal Cancer for Tumor Microenvironment and Cancer Prognosis: A Swedish Study from Tissue Microarrays to Big Data Analyses.

Shuwen Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.